U.S. Stock News

In the past week, Fidelity National Financial drew attention as investors reacted to its 14% return on equity, slightly above the 13% industry average, despite multi-year earnings declines. Expectations that the company’s payout ratio could fall to 30% and potentially lift future ROE to 18% are shaping a more optimistic view of its earnings power. We’ll now examine how expectations for a higher future ROE may influence Fidelity National Financial’s broader investment narrative and risk...

Why Magnolia Oil & Gas Is Back on Investors Radar Mizuho just upgraded Magnolia Oil & Gas (MGY) after taking a fresh look at its low breakeven wells, conservative balance sheet, and steady cash returns, arguing the stock now trades at an appealing free cash flow discount. See our latest analysis for Magnolia Oil & Gas. That upgrade comes after a choppy stretch, with the share price down on a 3 month and year to date basis even as the 5 year total shareholder return of 221.47 percent indicates...

Omnicom Group (OMC) has been quietly grinding higher, with the stock up about 3 % in a day, 7 % over the week, and roughly 13 % in the past month. See our latest analysis for Omnicom Group. Despite that recent momentum, with a 30 day share price return of 13.24 %, Omnicom Group is still slightly negative on a year to date share price basis, while its five year total shareholder return of 59.18 % points to solid long term value creation. If Omnicom Group’s move has you rethinking where growth...

In early December 2025, Five Below reported third-quarter sales of US$1,038.29 million and net income of US$36.51 million, and raised its full-year 2025 outlook to net sales of US$4.62–4.65 billion and net income of US$306–316 million while confirming it had completed a US$69.46 million share repurchase program. The upgraded guidance, underpinned by higher comparable sales assumptions and continued store openings, highlights how Five Below’s merchandising reset and value-focused format are...

A new expert consensus paper backing Castle Biosciences (CSTL) DecisionDx Melanoma test has pushed the stock higher, as investors weigh what wider physician adoption could mean for growth and valuation. See our latest analysis for Castle Biosciences. The expert backing for DecisionDx Melanoma comes on top of an already powerful move in the stock, with a roughly 69 percent three-month share price return and a nearly 50 percent one-year total shareholder return. This suggests momentum is...

Commercial Metals (CMC) has quietly delivered a strong run lately, with the stock up about 19% over the past month and roughly 17% in the past 3 months, outpacing broader materials peers. See our latest analysis for Commercial Metals. Zooming out, Commercial Metals has posted a hefty year to date share price return of around 42 percent, and a five year total shareholder return north of 270 percent. This signals strong, sustained momentum as investors warm to its growth and earnings...

If you are wondering whether D-Wave Quantum is still a speculative story stock or if the current price actually makes sense for long term investors, this article will walk through the numbers behind the hype. The stock has been extremely volatile, dropping 11.2% over the last week but still up 4.2% over the past month, 147.5% year to date and 165.5% over the last year, with a 1,065.9% gain over three years. Much of this wild ride has been driven by excitement around its annealing based...

In recent days, multiple Wall Street firms, including UBS and Mizuho, reiterated positive ratings on Permian Resources and adjusted their research views, signaling confidence in the company’s outlook within the oil and gas sector. This cluster of upbeat analyst opinions, paired with an overall "Outperform" consensus, underscores how professional sentiment can influence investor perception and trading activity. Now, we'll explore how this wave of reaffirmed positive analyst sentiment...

Wondering if Fiserv is quietly turning into a value opportunity after a rough stretch, or if the market is still getting it wrong on price? Despite being down about 66.1% over the last year and 66.8% year to date, the stock has shown flickers of life recently, rising 2.6% in the last week and 9.0% over the past month to close around $68.33. Recent headlines have focused on Fiserv doubling down on its role in digital payments and banking infrastructure, including ongoing integrations of its...

Emerson Electric (EMR) has quietly outperformed many industrial peers this year, and with the stock hovering near 52 week highs, investors are asking whether current pricing still leaves enough upside on the table. See our latest analysis for Emerson Electric. The latest pullback sits against a solid backdrop, with a roughly 8 percent year to date share price return and an 82 percent five year total shareholder return suggesting momentum is cooling rather than breaking. If Emerson’s run has...

Earlier in December 2025, Super Micro Computer expanded its NVIDIA Blackwell architecture portfolio with new liquid-cooled HGX B300 systems, offering higher GPU density, improved power efficiency, and turnkey rack-scale AI “factory” deployments for hyperscale, enterprise, and government data centers. At the same time, Supermicro’s work with partners such as Cornelis and EdgeMode highlights how liquid cooling, high-speed networking, and sustainable infrastructure are becoming central to...

Earlier in December 2025, Wave Life Sciences completed a roughly US$350.00 million follow-on equity offering, issuing 15,789,475 ordinary shares at US$19 each alongside 2,631,578 pre-funded warrants, after releasing positive interim Phase 1 INLIGHT data for obesity candidate WVE-007 showing improved body composition and a favorable safety profile. The combination of WVE-007’s early signs of durable, once- or twice-yearly obesity dosing potential and a sizable capital raise suggests Wave is...

Wondering if Tenet Healthcare's huge run up has already priced in the upside, or if there is still value left on the table for new investors? The stock has eased back about 2.5% over the last week, but is still up 2.1% over 30 days and 57.2% year to date, building on a 48.5% gain over 1 year and more than tripling over 3 and 5 years. Recent headlines have focused on Tenet's continued strategic focus on its ambulatory surgery and specialty care network, along with ongoing portfolio...

Wondering if Texas Roadhouse at around $165 a share is still a bargain or if the easy gains are gone? This piece will walk through what the current price is really baking in. The stock is roughly flat in the very short term, up 0.5% over the last week and down 0.9% over the past month. That sits against a tougher backdrop of an 8.5% drop year to date and a 9.9% slide over the last year, after a huge 81.4% and 124.5% run over the past 3 and 5 years respectively. Investors have been reacting...

If you are wondering whether Northrop Grumman at around $568 a share is still a smart buy, or if the big gains are already behind it, you are not alone. That is exactly what this breakdown will tackle. The stock is up 3.3% over the last week, 1.9% over the past month, and 21.5% year to date, building on a 20.5% gain over the last year and 108.4% over five years. Recent headlines have focused on Northrop Grumman's expanding role in defense and space programs, including high profile contracts...

If you are wondering whether AbbVie is still worth considering after its big run, or if its best days are behind it, this breakdown is for you if you care about what you are actually paying for the growth story. Despite a 25.0% gain year to date and a 34.2% rise over the last year, AbbVie has cooled off recently, slipping 0.4% over the past week and 4.1% over the past month after touching around $224.31. Recent headlines have focused on AbbVie's continued push to diversify beyond Humira with...

In its recently reported third-quarter results, Kirby posted revenues of US$871.2 million, a 4.8% year-on-year increase that exceeded analyst expectations by 2.3%, with management highlighting continued strength in coastal marine and power generation operations. This performance underlines Kirby’s ability to adapt to current industry conditions while converting demand in its core marine and power-focused businesses into tangible top-line growth. With Kirby surpassing revenue expectations on...

Wondering if Albemarle is finally a smart way to play the lithium story without overpaying for hype? You are not alone; this stock is back on a lot of watchlists. After a rough few years, Albemarle has bounced with a 1.1% gain over the last week, 14.5% over the last month, 58.1% year to date, and 51.9% over the last year, even though the 3 year and 5 year returns are still negative at -39.5% and -4.7%. Much of this renewed interest links back to shifting expectations around long term lithium...

AerCap Holdings (NYSE:AER) has quietly rewarded patient shareholders, with the stock climbing about 16% over the past 3 months and roughly 46% year to date, inviting a closer look at what is driving returns. See our latest analysis for AerCap Holdings. That mix of a 16.3% 3 month share price return and a powerful 54.9% 1 year total shareholder return suggests momentum is still building as investors reassess AerCap’s earnings power and capital returns. If AerCap’s run has you rethinking where...

If you are wondering whether Rexford Industrial Realty is quietly becoming a value opportunity or just fairly priced industrial real estate, you are in the right place. Rexford's share price now sits around $40.72, with returns of 2.7% over the last week, a modest 6.0% year to date, and 6.6% over the past year after a choppy 3 to 5 year stretch. Recently, the stock has been in focus as investors reassess demand for infill industrial properties in key coastal markets and the resilience of...

If you are wondering whether Ferrari's premium share price still makes sense or if there is a hidden opportunity here, you are in the right place as we unpack what the market is really paying for this brand. After an exceptional multi year run, with the stock up 76.7% over 3 years and 68.2% over 5 years, recent returns have cooled, with the share price down 1.3% over 7 days, 11.2% over 30 days and 11.0% year to date, contributing to a 13.7% drop over the last year. That pullback comes as...

Matador Resources (MTDR) has had a choppy run lately, with the stock bouncing between near term gains and a weaker year to date trend. This has left investors debating whether this pullback is an opportunity or a warning. See our latest analysis for Matador Resources. Zooming out, the recent 1 day share price gain sits against a much weaker year to date share price return and a softer 1 year total shareholder return. This suggests momentum has been fading even as long term holders remain well...

Devon Energy (DVN) just delivered a third quarter earnings beat that paired higher production with stronger free cash flow, and Wall Street quickly took notice, backing the stock with a wave of more constructive ratings. See our latest analysis for Devon Energy. The latest earnings surprise has helped Devon’s 1 day share price return of 5.3 percent stand out against a steadier backdrop. A 1 year total shareholder return of 22.1 percent and a 5 year total shareholder return above 200 percent...

NetApp (NTAP) shares have been drifting after a choppy few months, slipping over the past week but still modestly higher for the month. This sets up an interesting mismatch between recent volatility and longer term performance. See our latest analysis for NetApp. At around $110.95 per share, NetApp’s recent slide, including a weak 7 day share price return, looks more like a pause in what has been a solid multi year total shareholder return story. This suggests momentum is cooling rather than...